Ms Angela Tomasovic

Institute of Pharmacology and Toxicology, Wuerzburg (Germany)

Follow

Contributor content

The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

Presentation

The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

ESC 365 is supported by

novartis

Explore sponsored resources